Autolus Therapeutics PLC

AUTL·NASDAQ·$1.68·$447M

Financials

10-QQ2 ended 06/30/2608/11/2610-QQ1 ended 03/31/2605/14/2610-KFY 202503/27/2610-QQ3 ended 09/30/2511/12/2510-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report08/11/268-KCurrent report08/03/268-KCurrent report08/03/268-KCurrent report06/29/268-KCurrent report06/09/26

Prospectuses and Registrations

424B3Prospectus09/22/26S-3Shelf registration09/14/26S-3Shelf registration04/13/26S-3Shelf registration04/13/26424B3Prospectus01/26/26

Proxies

No matching filings.

Ownership

Form 4Insider transaction09/03/26144Proposed sale of securities09/02/26SC 13D/ABeneficial ownership (amended)08/28/26SC 13G/ABeneficial ownership (amended)08/14/26Form 4Insider transaction07/01/26

Other

EFFECTRequest for effectiveness09/22/26DEL AMDEL AM09/15/26EFFECTRequest for effectiveness05/05/26EFFECTRequest for effectiveness05/05/26CORRESPCorrespondence with the SEC05/01/26